Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Mercadolibre Inc (MELI) Price & Performance

AbCellera Biologics IncTrade
Mercadolibre IncTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Mercadolibre Inc — how do they compare? AbCellera Biologics Inc trades at $9.19 (market cap $2.99B), while Mercadolibre Inc trades at $1,930.02 (market cap $98.35B). The key difference: Mercadolibre Inc is far larger — about 32.9× AbCellera Biologics Inc's market cap, and Mercadolibre Inc is trading nearer its 52-week high, AbCellera Biologics Inc nearer its low. Which is the better fit depends on your goals.

ABCLMELI
Market Cap
$2.99B$98.35B
Sector
HealthConsumer Cyclical
52-Week High
$9.76$2.51K
52-Week Low
$2.78$1.55K
Enterprise Value
$2.58B$106.00B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Mercadolibre Inc

MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.

Read more on MELI